Search

everythinglearnresearchcommunity

for

Search:↓

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

A specific gene variant (rs4833095) is linked to a higher risk of alopecia areata in Koreans.

JW0061 may be a new treatment for hair loss by promoting hair growth through WNT signaling.

Ginsenosides Rb₁ and Rd may help prevent hair loss by promoting hair cell growth.

The compounds tested could potentially treat hair loss and alopecia.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The solid microneedle booster improves hair regrowth and follicle enrichment when used with minoxidil.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

A specific gene mutation causes a severe skin disorder in a family.

Using a call center to collect data in a trial for eye disease in diabetics led to high response rates and very little missing information.

The BUZZ gene is important for root hair growth and overall root structure in the plant Brachypodium distachyon.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.